Important targets for cAMP signalling in the heart are hyperpolarization-activated and cyclic nucleotide-gated (HCN) channels that underlie the depolarizing 'pacemaker' current, I f . We studied the role of I f in mice, in which binding of cAMP to HCN4 channels was abolished by a single amino-acid exchange (R669Q). Homozygous HCN4 R669Q/R669Q mice die during embryonic development. Prior to E12, homozygous and heterozygous embryos display reduced heart rates and show no or attenuated responses to catecholaminergic stimulation. Adult heterozygous mice display normal heart rates at rest and during exercise. However, following b-adrenergic stimulation, hearts exhibit pauses and sino-atrial node block. Our results demonstrate that in the embryo, HCN4 is a true cardiac pacemaker and elevation of HCN4 channel activity by cAMP is essential for viability. In adult mice, an important function of HCN4 channels is to prevent sinus pauses during and after stress while their role as a pacemaker of the murine heart is put into question. Most importantly, our results indicate that HCN4 channels can fulfil their physiological function only when cAMP is bound.
Introduction
Spontaneous activity of the mammalian heart is generated in the sino-atrial node (SAN). How pacemaker activity is generated in SAN cells and how pacemaking is regulated by the autonomous nervous system is still a matter of debate. A number of different ion channels and signalling events have been implicated in pacemaker activity (for review see, Couette et al, 2006) . Key players controlling the diastolic depolarization are the hyperpolarization-activated current I f and the L-type calcium current I Ca,L (DiFrancesco, 1993; Verheijck et al, 1999; Biel et al, 2002; Zhang et al, 2002; Mangoni et al, 2003; Barbuti et al, 2007) .
The I f current is mediated by hyperpolarization-activated and cyclic nucleotide-gated (HCN) channels. These channels have a number of particular features that enable them to open at voltages near the maximal diastolic potential (MDP). First, channels are activated on hyperpolarization of the membrane potential. Second, channel activity is dependent on the intracellular cAMP concentration ([cAMP] i ) (DiFrancesco and Tortora, 1991) . When cAMP binds to the cyclic nucleotide-binding domain (CNBD) of HCN channels, the activation curve shifts towards more positive voltages, thereby enhancing channel activity. In addition, channels with cAMP bound activate faster and deactivate slower. Thus, an increase of [cAMP] i , for example, during b-adrenergic stimulation, enhances I f , whereas a decrease of [cAMP] i , for example, during muscarinic stimulation, attenuates I f (DiFrancesco et al, 1986; DiFrancesco and Tromba, 1988) . It has been proposed that cAMP modulation of I f is the primary pathway by which the autonomous nervous system controls the heart rate (Bucchi et al, 2003) . Consistent with this model, mutations in the HCN4 channel gene, the major isoform in the SAN, are associated with sinus bradycardia and arrhythmia (Schulze-Bahr et al, 2003; Milanesi et al, 2006) .
The other key player in cardiac pacemaking is the voltagedependent Ca 2 þ channel Ca v 1.3 that carries I Ca,L . The I Ca,L is activated during the early phase of the diastolic depolarization, and inhibition of I Ca,L induces bradycardia in vivo (Lande et al, 2001) . Moreover, Ca v 1.3 knockout mice are bradycardic and show sino-atrial arrhythmia (Platzer et al, 2000; Zhang et al, 2002; Mangoni et al, 2003) . These observations have led to the proposal that in SAN cells Ca v 1.3 channels generate a significant electrical signal contributing to the diastolic depolarization . Within the framework of this model, the increase of I Ca,L during cAMP stimulation enhances the pacing component.
In addition to I f and I Ca,L , at least three other ionic pathways contribute to the regulation of the heart rate. One pathway is I Ca,T , which is almost exclusively mediated by Ca v 3.1 channels . Ca v 3.1 knockout mice exhibit pronounced bradycardia and a significant slowing of atrioventricular (AV) conduction . Another current implied in pacemaker generation is a sustained inward current, I st , which was identified in spontaneously beating SAN cells (Guo et al, 1995) . Its proposed role in cardiac pacemaking is largely based on numerical simulations of pacemaker activity (Shinagawa et al, 2000; Zhang et al, 2002) . The impact of I st on pacing the heart is difficult to estimate due to its unidentified molecular nature and the lack of specific pharmacological tools to target this current. Finally, rhythmic Ca 2 þ oscillations have been proposed to be involved in cardiac pacemaking. This proposal challenges the major role of I f in primary pacemaker activity of the SAN and its role in the autonomous regulation of the heartbeat (Bogdanov et al, 2001; Kodama et al, 2002; Lipsius and Bers, 2003) . Instead of I f , electrogenic Na þ /Ca 2 þ exchange has been proposed to provide the major depolarizing pacemaking current. According to this model, SAN cells generate rhythmic, submembrane Ca 2 þ oscillations via spontaneous opening of ryanodine receptors in the sarcoplasmatic reticulum (SR) (Bogdanov et al, 2001) . Thereby, the intracellular Ca 2 þ concentration is locally increased and the Na þ /Ca 2 þ exchanger in the plasma membrane is activated. An inward current is generated that depolarizes the cell. The frequency of spontaneous Ca 2 þ release events is tightly controlled by the efficiency of Ca 2 þ uptake into the SR by the Ca 2 þ ATPase SERCA. The pumping rate of SERCA is highly sensitive to changes in [cAMP] i . An increase of [cAMP] i stimulates SERCA activity (for review see, Colyer, 1998; Kamp and Hell, 2000) , leading to a higher SR Ca 2 þ uptake and spontaneous Ca 2 þ events occur more frequently. The heart beats faster.
Here, we investigate the role of HCN4 in cardiac pacemaking of mice using a knock-in mouse model in which cAMP binding to the HCN4 channel has been abolished. Our results are both intriguing and unexpected. They demonstrate that (1) in the embryo, HCN4 is a powerful pacemaker but only when cAMP is bound and (2) in adult mice, HCN4 does not seem to contribute to cardiac pacemaking, but rather ensures stable heart rhythm during and after stress.
Results

Generation of HCN4 R669Q knock-in mice
To define the physiological function of I f and its modulation by cAMP more precisely, we generated knock-in mice that harbour a single amino-acid exchange (R669Q) in the CNBD of the HCN4 channel. This arginine residue is crucial for the binding of cAMP because it interacts with the negatively charged phosphate group (McKay et al, 1982; Bubis et al, 1988; Zagotta et al, 2003) . To ascertain that the mutation abolishes regulation by cAMP, we analysed the wild-type HCN4 and the mutant HCN4 R669Q channel in Flp-In-293 cells. In the absence of cAMP, the voltage-dependent activation of HCN4 R669Q mutant and wild-type channels was similar ( Figure 1A ). Voltages of half-maximal activation V 1/2 were À94.373.7 mV (n ¼ 8) for wild-type and À99.573.4 mV (n ¼ 7) for HCN4 R669Q channels. Cyclic AMP shifted the activation curve of the wild-type HCN4 channel by þ 24 mV (V 1/2 ¼ À70.672.7 mV (n ¼ 3)), whereas no shift was observed for the HCN4 R669Q mutant (V 1/2 ¼ À96.377.1 mV (n ¼ 5)). We introduced the mutation into the HCN4 gene locus of mice via homologous recombination in embryonic stem cells ( Figure 1B) . Integration of the targeting vector, germ-line transmission, and deletion of the neomycin resistance gene were confirmed by Southern blot and PCR analysis ( Figure 1C Figure 1E ), indicating that homozygous embryos die between E11 and E12.
The amino-acid exchange R669Q does not alter protein expression of HCN4 We were concerned about the similar lethal phenotype of HCN4 À/À (Stieber et al, 2003) and HCN4 R669Q/R669Q mice. To investigate whether the pattern or level of expression of the channel mutant is altered, we analysed the cellular HCN4 distribution during embryonic development prior to E11.5. Different HCN4-specific antibodies labelled the same region in the heart of HCN4 þ / þ and HCN4 R669Q/R669Q embryos ( Figure 2A ). No obvious difference existed in the cellular distribution of the HCN4 channel in wild type compared to the HCN4 R669Q channel in homozygous embryos ( Figure 2A , middle panel). A monoclonal, HCN4-specific antibody (specificity of HCN4 antibodies shown in Figure 2C ) labelled two bands in western blots of membrane proteins from Flp-In-293 cells that expressed the HCN4 or the HCN4 R669Q channel ( Figure 2B ). Treatment with PNGase F revealed that the upper band represents a glycosylated form of the HCN4 channel. In western blots of proteins isolated from wild-type, heterozygous, and homozygous embryonic hearts, the antibody recognized the same protein bands with equal intensities, demonstrating that the mutation does not affect the level of HCN4 expression ( Figure 2D ).
HCN4
R669Q/R669Q embryonic mice display reduced basal heart rates We analysed the spontaneous beat frequency of hearts isolated from HCN4 þ / þ , HCN4 þ /R669Q , and HCN4 R669Q/R669Q embryos prior to E11.5. Under basal conditions, hearts from heterozygous and homozygous embryos beat regularly without obvious arrhythmias; however, the heart rate was significantly slower compared to hearts from wild-type embryos ( Figure 2E and Table I ). Furthermore, in wild-type embryos, the heart rate increased from E9 to E11 ( Figure 2E and Table I ), thereby enhancing supply of nutrients and oxygen necessary for proper development. This increase was not observed in HCN4 þ /R669Q embryos, and in HCN4 R669Q/R669Q embryos, the heart rate was even further reduced from day 9.5 to 11.5 ( Figure 2E ). Notably, heart rates from HCN4 R669Q/R669Q and HCN4 À/À embryos at E9.5 (Stieber et al, 2003) are virtually identical, indicating that the Arg669Gln exchange completely eliminates the pacing function of the HCN4 channel.
Adrenergic stimulation does not accelerate the heart rate of HCN4 R669Q/R669Q embryonic mice
Isoproterenol superfusion increased the rate of isolated hearts from HCN4 þ / þ and HCN4 þ /R669Q embryos (37.474.5%
(n ¼ 8) and 19.872.8% (n ¼ 6), respectively), whereas no increase was observed in hearts from HCN4 R669Q/R669Q embryos (2.872.5% (n ¼ 5); Figure 2F and G). Similarly, superfusion with NKH477, a drug that specifically activates adenylyl cyclases, increased the heart rate from HCN4 þ / þ and HCN4 þ /R669Q embryos (22.671.7% (n ¼ 14) and 14.272.6% (n ¼ 13), respectively), but not from HCN4 R669Q/R669Q embryos (1.971.9% (n ¼ 5); Figure 2H and I). These results demonstrate that HCN4 is the principal target for cAMP during the embryonic stages analysed in this study. An acceleration of heartbeat frequency during b-adrenergic stimulation is only possible when cAMP binds to HCN4. 
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þ / þ at the same developmental stage; f Po0.05 compared to the same genotype at E9.5. (F) Effect of isoproterenol (2 mM) on the embryonic heart rate (
, green; HCN4 R669Q/R669Q , blue). Data have been normalized to the rates during superfusion with BM. (G) Increase in heart rate (at 9 min) during perfusion with isoproterenol. Data have been normalized to the corresponding heart rate during superfusion with BM (grey, basal heart rate; yellow, heart rate at 9 min). Statistical analysis: student's t-test; *Po0.05 compared to basal heart rate; The I f of HCN4 R669Q/R669Q cardiomyocytes activates slower and deactivates faster To characterize genotypic differences of cardiomyocytes, we recorded I f currents and action potentials from cultured cells of HCN4
, and HCN4 R669Q/R669Q embryonic hearts. Isolated beating cells were studied with the patch-clamp technique in the whole-cell configuration. The I f current was activated by hyperpolarizing voltage steps from a holding voltage of À55 mV to test voltages up to À135 mV. Subsequently, a voltage step to À95 mV was ap- 
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Normalized heart rate plied to probe the activation state of HCN channels. We observed robust I f currents in all three genotypes. Figure 3A and B shows currents from cardiomyocytes of wild-type and homozygous embryos, respectively. The I f current of wildtype cardiomyocytes activated faster and more completely than that of HCN4 R669Q/R669Q cells ( Figure 3A and B). Therefore, we analysed the kinetics of I f current activation and deactivation in more detail. Figure 3C shows current responses of wild-type and homozygous cells to steps from the holding voltage (À55 mV) to the test voltage (À95 mV) and back to the holding voltage. We fitted simple exponential models to the respective current traces ignoring the initial delay at the onset of activation (see Figure 3C ). While for the homozygous genotype a single exponential with a time constant of 17577132 ms (n ¼ 16) was sufficient to describe activation, two time constants of 264735 ms (relative amplitude 0.35) and 17717474 ms (relative amplitude 0.65) (n ¼ 11) were necessary to describe wild-type currents. Similarly, deactivation of homozygous currents was well described by a single time constant of 172723 ms (n ¼ 9), while for wild-type currents two time constants of 200738 and 16907314 ms (n ¼ 8) were necessary for a satisfactory fit. The additional time constant for wild-type currents was fast in the case of activation and slow in the case of deactivation, demonstrating that in wild type, currents activated faster and deactivated slower compared to currents of homozygous cells. Table II summarizes the results of the kinetic analysis. We have included in Table II also the kinetic  analysis of the activation of heterologously expressed HCN4  and HCN4 R669Q channels. The activation properties of wildtype cardiomyocytes are strikingly similar to those of heterologously expressed HCN4 currents in the presence of cAMP (see Table II ).
The voltage-dependent activation of I f in cardiomyocytes differs among genotypes Next, we analysed tail currents as in Figure 3A and B to determine the voltage dependence of activation of I f for the different genotypes. The voltage of half-maximal activation (V 1/2 ) in the three genotypes differed significantly: V 1/2 was À82.573.2 mV (n ¼ 12) for wild-type, À89.376.6 mV (n ¼ 12) for heterozygous, and À95.774.5 mV (n ¼ 9) for homozygous cardiomyocytes ( Figure 3D ). This result is reminiscent of the differences observed with heterologously expressed HCN4 and HCN4 R669Q channels in the presence of cAMP (compare Figure 2A) . However, for the experiments presented here, no exogenous cAMP was added. We interpret this result to indicate that even in the unstimulated state, the I f in wild-type and heterozygous cardiomyocytes is significantly upregulated by cAMP. Figure 3E , lower panel), ADPs from 5 to 800 ms, and MDPs from À61.5 to À87 mV. On average, rates were significantly lower in HCN4
We reasoned that cells with the highest spontaneous rates eventually pace the embryonic heart. In wild-type embryos, we identified pacemaker-like cardiomyocytes (9 of 32 cells) with particularly high average rates of 211720 b.p.m. (n ¼ 9), MDPs of À75.770.7 mV, APDso100 ms, and robust I f currents when voltage clamped. In the presence of cAMP (100 mM in the pipette solution), this cell population displayed beat frequencies of 338741 b.p.m., indicating a pronounced stimulatory effect of cAMP. Action potentials of a typical wild-type cell from this population are shown in Figure 3F (upper panel). The cell is spontaneously active at about 240 b.p.m. We then searched for HCN4 R669Q/R669Q cells that produced the same action potential shape (APDo100 ms) characteristic of this particular class of cells. In total, 8 of 32 cells were found with action potential shapes similar to the ones we were looking for. These cells were characterized by a relatively slow rate of 9279 b.p.m. (n ¼ 8) and MDPs of À82.670.7 mV. Figure 3F (middle panel) shows a typical example. The cell was active with 75 b.p.m. and had an MDP of À83 mV. When we injected a depolarizing current of 20 pA into this cell ( Figure 3F , lower panel) to compensate for the poor activation of the HCN4 R669Q/R669Q channel, action potential rates increased drastically to values otherwise not observed in HCN4 R669Q/R669Q cells. Under these conditions, rate, action potential shape, and MDP were very similar to the wild-type pacemaker cell types at this developmental stage.
The I f of HCN4
R669Q/R669Q cardiomyocytes is unresponsive to changes in cAMP We next studied I f currents in the presence of exogenous cAMP (500 mM). Under this condition, the V 1/2 value of I f currents from wild-type cardiomyocytes was further shifted by 6 to À76.272.9 mV (n ¼ 6), while that from homozygous cardiomyocytes was largely unchanged (V 1/2 ¼ 92.374.9 mV, n ¼ 6) ( Figure 3G ). The small shift of V 1/2 by 6 mV in wild-type cells compared to a shift by 24 mV for heterologously expressed HCN4 channels supports the notion that the level of cAMP in cardiomyocytes is unusually high in the resting state. Therefore, the dynamic range of changes in cAMP is restrained and the extent of regulation of I f is accordingly smaller.
We reasoned that inhibition of basal adenylyl cyclase activity should abolish the genotypic differences in V 1/2 . Muscarinic modulation is known to inhibit adenylyl cyclase. We stimulated cells with carbachol (10 mM in the bath solution) and studied the effect on I f currents in wild-type and homozygous cardiomyocytes. While I f of homozygous cardiomyocytes was unaffected by carbachol, some wild-type cells displayed I f with a more negative activation curve. However, the action of carbachol was variable (range of V 1/2 of wild-type I f from À84 to À98 mV), indicating that the muscarinic system may not be homogeneously expressed in all cardiomyocytes. Consequently, we used the adenylyl cyclase inhibitor MDL12330 (10 mM in the pipette solution) to directly inhibit cAMP synthesis in cardiomyocytes. In the presence of MDL12330, all genotypes displayed the same V 1/2 of À101 mV ( Figure 3G ). This result strongly supports the notion that a high resting cAMP level is responsible for the differences in I f and, accordingly, for the differences in heart rate between the three genotypes.
I f current densities do not differ among genotypes
Some mutations in the CNBD of HERG channels have been proposed to induce trafficking defects, that is, fewer channels are incorporated into the plasma membrane (for review, see Thomas et al, 2003) . To investigate whether Arg669 is also important for trafficking, we determined I f current densities of embryonic cardiomyocytes at different developmental stages. We used the time-resolved component of I f at À135 mV (full activation) for this analysis. Figure 3H summarizes the results. We observed no significant genotypic differences of I f current density at days E9.5 or E10.5. Furthermore, no significant increase of I f current density was observed in wild-type cells from E9.5 to E11.5, indicating that the increase of heart rate observed during this developmental window is probably not caused by an enhanced expression of I f currents. HCN currents have been shown to exhibit an instantaneous current component (Gauss et al, 1998; Macri and Accili, 2004; Mistrik et al, 2006; Proenza and Yellen, 2006; Lin et al, 2007) . We determined the current density of the instantaneous current (including leak) at À95 mV for the three genotypes. We observed no genotypic differences (mean (median)7s.d. (number of experiments); wild-type, 2.5 (1.8)72.5 pA/pF (n ¼ 38); HCN4 þ /R669Q , 1.8 (1.6)71.3 pA/pF (n ¼ 24); HCN4 R669Q/R669Q , 2.0 (2.0)7 1.3 pA/pF (n ¼ 15)). PI 3 kinase is not responsible for the genotypic differences of I f Finally, we studied whether I f currents of wild-type and homozygous cardiomyocytes are differently regulated by phosphoinositide 3 (PI 3 ) kinase. Recently, it has been shown that PIP 2 can act as a ligand that allosterically opens HCN channels by shifting the activation curve to more positive potentials (Pian et al, 2006; Zolles et al, 2006) . We studied the activation of I f after incubation of cardiomyocytes with wortmannin (10 mM in the bath solution) for at least 30 min. While the V 1/2 values of both, wild type and HCN4 R669Q/R669Q , were shifted to more negative values by wortmannin treatment (7.7 and 6.2 mV, respectively), the difference of V 1/2 among genotypes was unchanged ( Figure 3I ). We conclude that there is no differential regulation of wild type and mutant I f by PI 3 kinase. Taken together, our results indicate that wild-type I f is enhanced by cAMP at rest and that this acceleration is indispensable for pacemaker activity of I f .
Heart rates in adult mice do not differ between genotypes
The differences in basal heart rate and in the activation of I f between wild-type and heterozygous embryos prompted us to study the heart rate in freely moving adult HCN4 þ / þ and HCN4 þ /R669Q mice by telemetric recording of electrocardiogram (ECG). Neither the heart rate at rest nor during exercise or mental stress was different between genotypes ( Figure 4A and C). The heart rate of sedated animals and the intrinsic rate of the isolated heart were also not different between genotypes ( Figure 4B and C), nor was the electrophysiology of the AV node and the ventricle ( Figure 4C ). After exercise, HCN4 þ /R669Q mice developed pauses and sino-atrial block more often than their wild-type littermates (HCN4
: 977 pauses/55min, median 6.5, range 2-25; HCN4 þ / þ : 6.575 pauses/55 min, median 1, range 0-14, Po0.05). Sino-atrial block and sinus pauses were also found in spontaneously beating, Langendorff-perfused hearts, mostly during washout of the b-adrenoceptor agonist orciprenaline (baseline: pauses in 4/10 HCN4 þ /R669Q hearts versus 1/9 HCN4 þ / þ hearts; during orciprenaline infusion: pauses in 5/10 HCN4 þ /R669Q versus 1/9 HCN4 þ / þ hearts; during washout of orciprenaline: pauses in 8/10 HCN4 þ /R669Q versus 0/9 HCN4 þ / þ hearts, Po0.05 for
Discussion
The role of I f in embryonic and adult cardiomyocytes is a matter of a long-lasting debate (Kodama et al, 2002; Lipsius and Bers, 2003) . While some groups favour I f as the principle pacemaker current of SAN cells, others attribute only a minor modulatory function to this current. We studied here knockin mice that carry a single amino-acid exchange in the CNBD of the HCN4 channel, which represents the major component of the I f current in SAN cells (Stieber et al, 2003) . Our results provide the following insights. First, hearts from HCN4 R669Q/R669Q embryos show virtually no response to catecholaminergic stimulation, indicating that the HCN4 channel is the major if not only target for cAMPmediated acceleration of the heart rate by catecholamines. Furthermore, this result shows that protein phosphorylation by another important target of cAMP signalling, cAMP-dependent protein kinase, is not involved in cardiac pacemaking at this developmental stage. The b-adrenergic acceleration of the heart rate is crucial for survival of the embryo (Portbury et al, 2003; Chandra et al, 2006) . Adrenergic stimulation maintains the embryonic heart rate during transient hypoxia that occurs during gestation. Hypoxia induces a life-threatening bradycardia unless catecholamine release compensatorily accelerates the heart rate (Portbury et al, 2003) .
The fatal outcome of the HCN4 R669Q/R669Q knock-in model demonstrates the outstanding role of HCN4 as the key transducer of catecholaminergic signalling in the embryonic heart ensuring survival of the embryo.
Another key observation of our study is that even in the absence of adrenergic stimulation, the rates of heterozygous þ /R669Q heart shows three pauses with doubling of cycle length, consistent with sino-atrial block. (C) Electrophysiological measurements in sedated animals, freely moving animals and in the isolated, beating heart. All values are given as mean7s.e.m. There were no significant differences among groups. Rates in the isolated hearts include hearts with sino-atrial block. This explains the relatively large s.d. in this group during orciprenaline treatment.
and homozygous hearts were significantly slower than those of wild-type hearts. This genotypic difference persisted in isolated cells where the I f current displayed different activation properties: the activation curve of wild-type I f was significantly shifted towards more positive voltages compared to that of homozygous cells. In heterozygous cells, this shift was smaller. The shift can be accounted for by high basal adenylyl cyclase activity resulting in high cAMP levels. Indeed, blocking adenylyl cyclase activity with MDL12330 completely eliminates differences in the activation curves of I f . Moreover, Vinogradova et al (2006) have recently shown that the basal cAMP level in rabbit SAN cells is markedly higher than in other cardiac cell types. Finally, even in noncardiac cells, namely GH(3) immortalized pituitary cells, basal cAMP levels significantly contribute to HCN channel activity (Kretschmannova et al, 2006) .
One of the most striking observations was that the resting beat frequency of embryonic HCN4 R669Q and HCN4
À/À (Stieber et al, 2003) hearts did not differ. The HCN4 R669Q channel, while present at similar density as the HCN4 channel in wild-type cardiomyocytes and proven functional, seems not to contribute to the pacing of the embryonic heart. Obviously, additional pacemaker mechanisms besides I f must exist in the embryonic heart that are responsible for the residual heart rate found in homozygous embryos. We investigated the beating properties of wild-type and homozygous cells in detail. In HCN4 þ / þ cells, we identified a cell type with especially high beating rates that we consider the pacemaker cells of the embryonic heart. A cell population with very similar action potentials was also found in the HCN4 R669Q/R669Q preparation. In this respect, our knock-in mouse model differs from the HCN4 knockout model, in which no 'mature' pacemaker cells were found (Stieber et al, 2003) . The rates of these 'pacemaker-like' HCN4 R669Q/R669Q cells were much lower than those in wild-type cells. Indeed, other cell types of the HCN4 R669Q/R669Q heart exhibited higher rates than this particular cell population. Most of these other cells displayed I f currents, however, some were devoid of I f . We speculate that in the HCN4 R669Q/R669Q heart probably these other cell populations take over to pace the heart, albeit with reduced rates.
If we assume that cells with I f are involved in pacemaking, why are the rates of HCN4 R669Q/R669Q and HCN4 À/À identical?
First, the MDP of most of the cells recorded here adopts values of about À75 mV. At this voltage the open probability of the HCN4 R669Q channel is only B4%, as determined from the voltage dependence of activation. Most likely, the depolarizing action of the HCN4 R669Q/R669Q channel is too small to be of any significance. The channel, in the absence of cAMP, becomes physiologically silent. Second, in HCN4
À/À as well as HCN4 R669Q/R669Q embryos other mechanisms may compensate the effect of the deletion or mutation of the HCN4 channel. This is expected to result in the same heart rate in both mouse lines. However, other HCN channel isoforms are not upregulated in HCN4 knockout mice (Stieber et al, 2003; Herrmann et al, 2007) and other potential mechanisms have not been studied so far.
In light of these findings and models of heart-rate regulation in the SAN , the normal heart rate of adult heterozygous HCN4 R669Q mice at rest and during exercise is unexpected. While hearts of heterozygous embryos display significantly reduced rates and attenuated responses to catecholamines, no such genotypic differences exist in adult hearts. Different scenarios can be envisioned to interpret this result. First, during development, other pacemakers may compensate the bradycardic effect of the channel mutation. In humans, the situation might be different. Mutations in or near the CNBD of HCN4 have been found to lead to a profound bradycardic phenotype in humans (Schulze-Bahr et al, 2003; Milanesi et al, 2006) . The molecular phenotype of one of these mutations was somewhat milder than the one investigated here. The mutated channels in this study are activated at more negative voltages than wild-type channels (Milanesi et al, 2006) . Interestingly, the negative shift of V 1/2 was only 8.4 mV, less than the shift we observed for the I f in homozygous cardiomyocytes (13 mV). Thus, a putative compensatory mechanism is lacking in humans. While a compensatory mechanism cannot be discarded, we favour a different interpretation of the identical heart rates in wild-type and heterozygous mice. During embryonic development of the mouse, the role of I f may switch from that of a major pacemaker to one that backs up other pacing elements in the adult. In fact, while this manuscript was in preparation, Herrmann et al (2007) published their work on a mouse model in which the HCN4 channel has been deleted cardiac specifically in adult mice. Mutant mice showed no defect in heart-rate regulation during sympathetic stimulation, but exhibit cardiac arrhythmia characterized by sinus pauses. The phenotype is similar to that of adult heterozygous HCN4
þ /R669Q mice. It will be interesting to investigate the cardiac phenotype of adult homozygous HCN4 R669Q/R669Q mice to study whether these animals display the phenotype observed in knockout mice. This experiment would test the idea whether cAMP binding is indispensable for the physiological function of HCN4 channels rather than only modulatory. From our results and the similar observation of Herrmann et al (2007) , we conclude that in adult mice, HCN4 channels serve a back-up mechanism that maintains a stable heart beat in situations during and after stress. HCN4 channels are probably no longer involved in sympathetic stimulation of the heart rate.
In humans, the role of HCN4 obviously is different. How can we explain these species-dependent differences? The most obvious difference in cardiac function between mice and humans is the frequency of the beating heart (60-200 b.p.m. in humans versus 500-1000 b.p.m. in mice). The beating frequency in humans is similar to the one in embryonic mice, where we have shown that HCN4 is a true pacemaker. We suggest that HCN4 can only serve as pacemaker at low beating frequencies; at higher frequencies, its slow activation characteristics are not suitable to support higher heart rates.
Materials and methods
Cloning of the targeting vector for the generation of HCN4 knock-in mice A genomic clone containing exons IV-VIII of the HCN4 gene was isolated from a mouse genomic 129/SvJ library (Stratagene, Amsterdam, The Netherlands). The library was probed with a cDNA fragment encoding the S5 to S6 region of mHCN4. A clone of roughly 11.7 kb was subcloned into pBluescript SK(À) (Stratagene), sequenced, and used for the construction of the targeting vector. The vector was constructed in neo-flox-8 by using a 1.8-kb genomic fragment as short arm of homology and a 4.4-kb genomic fragment as long arm of homology. The short arm was generated by ligating an AatII/HindIII fragment of the genomic clone together with a HindIII/XbaI-digested PCR product (forward: 5 0 -TCAGAAGCTTG GAGGGACCC-3 0 ; reverse: 5 0 -CCACTtctAGAACCCTCAATGGAA-3 0 ) into the AatII/XbaI-digested neo-flox-8. The long arm was generated by ligating an SphI/NsiI fragment of the genomic clone with a NotI/Asp718-digested PCR product (forward: 5 0 -TCTCA GATGGCgGccgcAGCACTTGTGTT-3 0 ; reverse: 5 0 -ACTGGGTACCA GCAGCACCC3 0 ) as well as an Asp718/SphI-digested PCR product that carries the mutation CG to AG in exon VII into the NotI/NsiIdigested neo-flox-8 containing the short arm. The mutated PCR fragment was generated by subcloning an Asp718/NarI fragment into pBluescript SK(À) and using this subclone as a template for a recombinant PCR performed with the 'QuikChange site-directed mutagenesis kit' (Stratagene) (forward: 5 0 -GACCCGGGGTCGGCa gACAGCCAGCGTCAG-3 0 ; reverse: 5 0 -CTGACGCTGGCTGTctGCC-GACCCCGGGTC-3 0 ). For negative selection, a diphtheria toxin A (DTA) cassette was inserted at the 5 0 end of the short arm. The DTA cassette has been amplified on pGEMTeasyDTA2 (forward: 5 0 -AATGACGTCCGGTACCTCGACG-3 0 ; reverse: 5 0 -ACTGACGTCCG GTACCTTAATTAA-3 0 ) and subcloned into pBluescript. An AatII fragment was excised and cloned into the AatII site of the targeting vector.
Generation of HCN4 knock-in mice
The vector was linearized with NsiI and electroporated into V6.5 embryonic stem cells (Rideout et al, 2000) . Positive clones were identified by Southern blot analysis with 5 0 and 3 0 probes. Blastocyst injection was performed for three independent clones. Male chimeras were crossed with C57BL/6J females (Jackson Laboratories, Bar Harbor, ME, USA). The neomycin resistance gene was removed by crossing heterozygous mice with deleter-cre mice (Schwenk et al, 1995) . Heterozygous mice were backcrossed for 10 generations to a C57BL/6J background.
Embryos were genotyped by PCR of yolk-sac DNA, and mice by PCR of tail DNA using the following primer set: primer no. 1: 5 0 -CTTAGTGGTAGACTGTTGTGGTT-3 0 and primer no. 2: 5 0 -GCTGG CTGTGCGCCGACCC-3 0 amplifying a 586-bp wild-type fragment, primer no. 3: 5 0 -TCTGACGCTGGCTGTCTG-3 0 and primer no. 4: 5 0 -CCATTGAGGGTTCTAGACTC-3 0 amplifying a 1804-bp fragment in HCN4 þ /neoR669Q mice and a 610-bp fragment after excision of the neomycin resistance gene.
Isolation and culture of embryonic hearts and cardiomyocytes
Embryos from timed matings were removed from pregnant females and transferred to pre-warmed PBS (in mM): NaCl 137; KCl 2.7; Na 2 HPO 4 10; and KH 2 PO 4 1.8. For analysis of the beat frequency, hearts were dissected, placed into DMEM (Gibco, Karlsruhe, Germany) containing 10% FBS (Gibco), and cultured over night at 371C, 10% CO 2 . During measurements, hearts were superfused with DMEM containing 10 mM HEPES/NaOH pH 7.4 (basal medium, BM). Drugs were added to BM (isoproterenol: 2 mM; NKH477: 100 mM). For isolation of cardiomyocytes, hearts were dissected and placed in a solution containing (in mM): NaCl 120, KCl 5.4, MgSO 4 5, sodium pyruvate 5, taurine 20, HEPES 10, glucose 20, CaCl 2 0.03, and 1 mg/ml collagenase B (Roche Diagnostics, Mannheim, Germany). The incubation was stopped with DMEM containing 20% FBS, 1% non-essential amino acids (Gibco), 1% penicillin/streptomycin (Gibco), and 100 mM b-mercaptoethanol (Sigma, Seelze, Germany). Cardiomyocytes were placed in a shaker at 371C for 30 min, plated onto 3 cm dishes, and incubated at 371C, 5% CO 2 for 24-72 h.
Western blot analysis and immunohistochemistry
Ten embryonic hearts from each genotype were pooled and homogenized in lysis buffer (in mM): NaCl 10, EDTA 2, HEPES 25, DTT 3, supplemented with 0.5 mg/ml Pefabloc SC. HEK293 cells were lysed in lysis buffer (in mM): Tris-HCl (pH 7.6) 10, NaCl 140 and 1% Triton X-100, supplemented with 0.5 mg/ml Pefabloc SC. Membrane proteins from R669Q cells were isolated as described (Wachten et al, 2006) . Proteins were separated on a 7.5% SDS-PAGE, blotted, and probed with one of the following antibodies: monoclonal HCN4-specific antibody (PG2-7H9, rat, 1:2) (Harzheim, 2006; Mataruga, 2006) , polyclonal, affinity-purified HCN4-specific antibody (HCN4-b, rabbit, 1:2000) (Mataruga, 2006) , monoclonal HCN1-specific antibody (RTQ-7C3, rat, 1:100) (Scholten, 2001 ), polyclonal, affinity-purified HCN2-specific antibody (HCN2-a, rabbit, 1:1000) (Mataruga, 2006) by using a chemiluminescence detection system. For reprobing with either a monoclonal a-actinin antibody (sarcomeric, mouse; Sigma, 1:1000) or a polyclonal anti-actin antibody (rabbit; Sigma, 1:200) the membranes were incubated in stripping buffer (in mM): Tris-HCl (pH 6.7) 62.5, b-mercaptoethanol 100, and 2% SDS for 30 min at 651C, washed with PBS and probed again. For immunohistochemical analysis, embryos were fixed in 5% paraformaldehyde, cryo-protected in 10 and 30% sucrose, and embedded in Tissue Tek (Sakura Finetek, Zoeterwoude, The Netherlands) at À201C. Frozen sections (16 mm, sagittal) were pre-incubated in blocking buffer (PBS, 0.5% Triton X-100, 5% Chemiblocker). Sections were incubated with the HCN4-specific antibodies (SHG-1E5: monoclonal, rat, 1:5: PPc73K: polyclonal, rabbit, 1:400 (Scholten, 2001 )) overnight and with the secondary antibodies (Alexa Fluor 488 goat anti-rat IgG; Molecular Probes, Karlsruhe, Germany; CY3 donkey anti-rabbit IgG, 1:500; Dianova, Hamburg, Germany) for 1 h in phosphate buffer containing 5% Chemiblocker. The labelled cryo-sections were analysed with a confocal laser-scanning microscope (Leica TCS, Solms, Germany).
Electrophysiological measurements
We recorded from cells with the patch-clamp technique in the whole-cell configuration. The pipette solution contained (in mM): K þ aspartate 130, NaCl 10, MgCl 2 2, EGTA 1, HEPES 10, pH 7.2 (KOH). cAMP or MDL12330 was added to the pipette solution as indicated. Cardiomyocytes were bathed in BM. Wortmannin or carbachol were added to BM as indicated. Flp-In-293 cells expressing HCN4 and HCN4 R669Q channels were bathed in a solution containing (in mM): NaCl 140, KCl 5.4, CaCl 2 1.8, MgCl 2 1, HEPES 5, glucose 10, pH 7.4 (NaOH). All recordings were performed at 371C. All voltages given were corrected for liquid junction potentials.
ECG and telemetry
Six-lead surface ECGs were recorded in littermate pairs of mice (12 weeks old) during isoflurane inhalation (1-1.5%). Recordings of 10 s were used for signal averaging. To record an ECG in freely roaming animals, a telemetric ECG transmitter (DSI, St Paul, MN, USA) was implanted. The telemetric ECG was analysed during normal activity and periods of stress, that is, swimming and warm air jets, according to published protocols Knollmann et al, 2003; Fabritz et al, 2004) . All recordings were digitized (EMKA, Falls Church, VA, USA) at 2 kHz and analysed off-line.
Electrophysiological study of the isolated heart
To assess intrinsic heart rate and AV nodal conduction, the heart was rapidly excised and retrogradely perfused in a Langendorff apparatus. Ventricular monophasic action potentials, atrial and ventricular electrograms, and tissue bath ECGs were simultaneously recorded during spontaneous rhythm and during programmed atrial stimulation (incremental atrial pacing, constant pacing at 100 and 140 ms cycle length) at baseline and during perfusion with orciprenaline (1.7 mM) following published techniques Kuhlmann et al, 2006) .
All original recordings were scrutinized for arrhythmias. We analysed heart rate, AV nodal conduction, APD, and QT interval semi-automatically using custom-designed software (LabVIEW and EMKA). Sino-atrial block (2:1) was defined following accepted prespecified clinical criteria, that is, a sudden two-fold increase of PP interval. All analyses were blinded to genotype.
Statistical analysis
Data are expressed as mean7s.d. or mean7s.e.m. Statistical comparisons were carried out with Student's t-test.
